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Autism spectrum disorders (ASDs) comprise a heterogeneous group of pathological conditions, mainly of genetic origin, char-
acterized by stereotyped behavior, marked impairment in verbal and nonverbal communication, social skills, and cognition.
Interestingly, in a small number of cases, ASDs are associated with single mutations in genes encoding for neuroligin-
neurexin families. These are adhesion molecules which, by regulating transsynaptic signaling, contribute to maintain a proper
excitatory/inhibitory (E/I) balance at the network level. Furthermore, GABA, the main inhibitory neurotransmitter in adult life,
at late embryonic/early postnatal stages has been shown to depolarize and excite targeted cell through an outwardly directed ﬂux
of chloride. The depolarizing action of GABA and associated calcium inﬂux regulate a variety of developmental processes from
cell migration and diﬀerentiation to synapse formation. Here, we summarize recent data concerning the functional role of GABA
in building up and reﬁning neuronal circuits early in development and the molecular mechanisms regulating the E/I balance.
A dysfunction of the GABAergic signaling early in development leads to a severe E/I unbalance in neuronal circuits, a condition
that may account for some of the behavioral deﬁcits observed in ASD patients.
1.Introduction
Autism spectrum disorders (ASDs) comprise a complex and
heterogeneous group of pathological conditions including
autism, Rett and Asperger syndromes, and pervasive devel-
opmental disorder-otherwise nonspeciﬁed, characterized by
impaired social interactions, deﬁcits in verbal and nonverbal
communication, and a limited interest in the surrounding
environment associated with stereotyped and repetitive
behaviors [1]. The incidence of these disorders, which varies
between 10 and 20 per 10000 children, has risen dramatically
over the past two decades mainly because of the use of
broader diagnostic criteria and the increased attention of the
medical community [2]. Clinical signs are usually present at
the age of 3 years, but prospective studies of infants at risk
have demonstrated that deﬁcits in social responsiveness,
communication, and play could be present already at the age
of 6–12 months.
ASDs are the most heritable neurodevelopmental dis-
orders of early childhood. Genetic factors are thought to
account for ∼80% of autism cases, and since autism is
a spectrum of disorders, it is conceivable that in most cases
diﬀerent genes act in combination in diﬀerent individuals
[3]. Genes, interacting with epigenetic factors, may inﬂuence
neuronal migration, axon pathﬁnding, dendritic develop-
ment, synaptogenesis, and pruning, thus contributing to
alter neuronal connectivity and information processing [4].
Interestingly, a small percentage of ASDs patients carry
single mutations in genes encoding for synaptic cell adhe-
sion molecules of the neurexin (NRXN)-neuroligin (NLG)
families [5]. These include mutations in genes encoding for
NRXN1[6,7],forNLG3,NLG4[8–10],andforShank3[11].
Although rare, these mutations provide crucial information
on the synaptic abnormalities which possibly aﬀect ASDs
patients and point to synapses dysfunction as a possible
site of autism origin. Synapses are specialized intercellular
junctions which transfer information from a neuron to a
target cell, usually another neuron.
Several lines of evidence suggest that an impairment
of GABAergic transmission contributes to the development2 Neural Plasticity
of ASDs. GABA, the main inhibitory neurotransmitter in
adulthood is released by interneurons which contain the
GABA synthesizing enzymes glutamic acid decarboxylase
(GAD)65 and GAD67. GABAergic interneurons, which con-
stitute a heterogeneous group of cells, diﬀerently classiﬁed
in virtue of their anatomical, physiological, and molecular
features [12], represent only 10%–15% of the total neuronal
population. Nevertheless, they provide the functional bal-
ance, complexity, and computational architecture of neu-
ronal circuits [13]. They play a key role in regulating neu-
ronal excitability via feedback and feed-forward inhibition.
Axons of diﬀerent inhibitory cells target diﬀerent postsynap-
tic subcellular compartments, allowing them to selectively
control the output of pyramidal cells [14], thus providing
the temporal structure that orchestrates the activity of
neuronal ensembles leading to coherent network oscillations
[15].
While in the mature brain GABA acts as an inhibitory
transmitter, during the embryonic and the perinatal period,
this neurotransmitter depolarizes targeted cells and triggers
calcium inﬂux. GABA-mediated calcium signaling regulates
a variety of diﬀerent developmental processes from cell pro-
liferation migration, diﬀerentiation, synapse maturation,
and cell death [16]. Although the geometry and the cellular
and subcellular selectivity of GABAergic axons are mainly
genetically determined, axonal branching and arborization
are regulated by activity and experience and often require
brain-derived neurotropic factor (BDNF, [17]). Thus, sen-
sory stimulation contributes to shape neuronal circuits,
whereas sensory deprivation signiﬁcantly retards their mat-
uration [18–20].
Considering the multifacet of GABA activities particu-
larly during development, it is not surprising that distur-
banceofGABAergicsignalingcanresultinaberrantinforma-
tion processing, as found in neurodevelopmental disorders
such as ASDs. In particular, it has been hypothesized that at
leastsomeformsofautismresultfromanimbalancebetween
excitation and inhibition in local circuits involved in sensory,
mnemonic, social, and emotional processes. The resulting
hyperexcitability could disrupt the normal formation of
cortical maps leading to a relatively unstable state [21]. The
cortex is organized in vertical mini columns of functionally
related glutamatergic and GABAergic neurons that process
thalamic inputs. Local GABAergic circuits contribute to
control the functional integrity of minicolumns via lateral
inhibition. Interestingly, analysisof postmortem tissuesfrom
ASDs patients has revealed alterations in the number of mini
columns, in the horizontal spacing separating cell columns,
and in their internal structure [22] .T h ea b n o r m a lc y t o a r -
chitecture is often associated with an increased expression of
calbindin-, calretinin- and parvalbumin-positive GABAergic
interneurons [23]. In addition, changes in GAD65 and
GAD67 [24], in the mRNA encoding for these enzymes
[25–27], in GABAA [28, 29]a n dG A B A B receptors [30]
have been found in brain samples from ASDs patients. The
altered GABAergic function may reduce the threshold for
developingseizuresasdemonstratedbythehighcomorbidity
of ASDs with epilepsy (one third of ASDs patients have
seizures [31]). This further strengthens the hypothesis that
an unbalance between excitation and inhibition contributes
to these devastating neurological disorders.
This paper will focus on the functional role of GABA
in regulating developmental processes, their experience-
dependent reﬁnement and, at the network level, the balance
between excitation and inhibition. In addition, the implica-
tions that an altered GABAergic signaling may have in neu-
rodevelopmental disorders such as ASDs will be discussed
taking into account diﬀerent animal models.
2. GABA, a PioneerNeurotransmitter in
Neuronal CircuitsFormation
The construction of the brain relies on a series of well-
deﬁnedgeneticallyandenvironmentallydrivenfactorswhose
disruption leads to pathological disorders including ASDs.
During central nervous system development, a sequence
of temporally related events during which neurons prolif-
erate, migrate, diﬀerentiate, and establish proper synaptic
connections occurs [16]. Further reﬁnement of immature
networks needs adaptive processes involving experience- or
activity-dependentmechanisms,whichleadtotheformation
of new synapses and elimination of others. Using imag-
ing techniques and electrophysiological approaches, several
patterns of coherent activity have been characterized early
in development [32]. Uncorrelated spontaneous activity
consisting of calcium action potentials has been suggested
to play a crucial role in regulation of cortical neurogenesis
at late embryonic stages [16, 33]. At birth, synchronous
neuronal activity can be detected in the hippocampus and in
the neocortex. This relies ﬁrstly on the activation of intrinsic
conductances and gap junctions and later on synapse-driven
events. Thus, small cell assemblies coupled to gap junctions
generate nonsynaptic spontaneous plateau assemblies (SPAs,
[32], Figure 1).
These involve small groups of neurons and are associated
with sustained intrinsic membrane potential oscillations.
SPAs are modulated by oxytocin, a maternal hormone
essential for labour induction, which transiently converts
GABA action from excitatory to inhibitory [34]. As the
network matures and the density of functional synapses
increases, synaptic-driven network oscillations replace SPAs.
A downregulation in the expression of connexins via CREB
signalling,followingactivationofNMDAreceptors,maylead
to SPAs silencing [35]. Two diﬀerent patterns of network-
driven synaptic oscillations have been described: the giant
depolarizing potentials or GDPs [36]a n de a r l yn e t w o r k
oscillations or ENOs [37]. These are reminiscent of “long
oscillations”and“spindlebursts”,respectively,recordedfrom
the rat somatosensory cortex in vivo [38] or of discontinue
activity patterns observed in the EEG of preterm babies [39].
While ENOs (which usually precede GDPs) were initially
thought to constitute the cortical counterpart of hippocam-
pal GDPs, they have been shown to coexist with GDPs in
the neocortex [32]. In the neocortex, ENOs critically depend
on the activation of NMDA receptors [37]. In addition,
evidence has been provided that extrasynaptic NMDA
receptors activated by ambient glutamate generate a tonicNeural Plasticity 3
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Figure 1: Patterns of electrical activity observed at late embryonic/early postnatal stages in the cortex. E20: uncorrelated calcium spikes; P0:
Spontaneous Plateau Assemblies (SPAs) synchronized by gap junctions. P3–P5: early network oscillations (ENOs) mediated by glutamate.
P6–P8: giant depolarizing potentials (GDPs) mediated by GABA and glutamate. (Modiﬁed from [32]).
current, which contributes to depolarize the membrane, to
enhance cell excitability and to convert silent synapses into
functional ones [40] .T h ea c t i v a t i o no fN M D Ar e c e p t o r sb y
“ambient” glutamate would be facilitated by changes in
subunits composition [41], in voltage dependence of the
magnesium block [42] and in the high aﬃnity for glutamate
of extrasynaptic NMDA receptors.
Inthehippocampus,GDPsaregeneratedbythesynergis-
tic action of glutamate and GABA, which in the immediate
postnatal period, orchestrates neuronal ensembles via its
depolarizing and excitatory action [43]. Before synapses for-
mation, GABA depolarizes targeted neurons via a paracrine
type of action. GABA released in a calcium- and SNARE-
independent way by nonconventional release sites such as
growthconesandastrocytesdiﬀusesawaytoactivateextrasy-
naptic receptors [44]. The absence of an eﬃcient uptake
system will enable GABA to accumulate in the extracellular
spaceandtoreachaconcentrationsuﬃcienttoexertitsdistal
action. The depolarizing action of GABA would activate
voltage-dependent calcium channels and would facilitate
the relief of the voltage-dependent magnesium block from
NMDAreceptors,thusallowingcalciumentryandactivation
of second messengers.
Using network dynamics imaging, online reconstruction
of functional connectivity and targeted whole-cell record-
ings, it has been recently demonstrated that, in immature
hippocampal slices, functional hubs composed of subpop-
ulations of GABAergic interneurons with large axonal
arborizations are able to synchronize large neuronal ensem-
bles [45]. The depolarizing action of GABA in immature
neurons results from an outwardly directed ﬂux of chloride.
Chloride homeostasis is controlled by the Na-K-2Cl cotrans-
porter NKCC1 and by the K-Cl cotransporter KCC2 that
enhance and lower [Cl−]i,r e s p e c t i v e l y[ 46]. Due to the
low expression of the KCC2 extruder at birth, chloride
accumulates inside the neuron via NKCC1. The progressive
increase in the expression of KCC2 is responsible for the
developmental shift of GABA from the depolarizing to the
hyperpolarizing direction. KCC2 extrudes K+ and Cl− using
the electrochemical gradient for K+.C l − extrusion is weak in
immature neurons and increases with neuronal maturation.
The functional role of the depolarizing action of GABA
on early circuits development has been assessed by manip-
ulating the expression levels of KCC2 and NKCC1, respec-
tively. Thus, the premature expression of KCC2, has been
shown to convert the action of GABA from excitatory to
inhibitory and to impair the morphological maturation
of cortical cells, without altering their radial migration
[47]. This eﬀect can be mimicked by overexpressing the
inwardly rectifying K+ channel which lowers the membrane
potential and reduces cell excitability, strongly suggesting
that membrane depolarization caused by the early GABA
excitation is essential for the functional maturation of cor-
tical circuits in vivo. On the other hand, knocking down
the expression of NKCC1 to abolish GABAA-mediated
excitation,leadstoasigniﬁcantreductioninAMPAreceptor-
mediated synaptic transmission associated with a disrup-
tion of dendritic arborization and spines density further
indicating that the depolarizing and excitatory action of
GABA plays a permissive role in the formation of excitatory
synapses [48]. Interestingly, these eﬀects could be rescued
by over expressing a mutant form of voltage-independent
NMDA receptors, indicating that GABA depolarization
cooperates with NMDA receptor to regulate the formation
of excitatory synapses. It is worth noting that GDPs and
associated calcium transients act as coincidence detectors for
enhancing,inanassociativetypeofmanner,synapticeﬃcacy
at emerging GABAergic [49], and glutamatergic synapses
[50]. Using a “pairing” procedure, consisting of correlating
GDPs-associated calcium rise with stimulation of mossy
ﬁbers or Schaﬀer collaterals, in the CA3 and CA1 region,
respectively, we found that this procedure produced a strong
and persistent potentiation of synaptic responses (Figure 2).
Intheabsenceofpairing,nosigniﬁcantchangesinsynap-
tic eﬃcacy could be detected. Similar results were obtained
by progressively increasing the interval between GDPs and
mossy ﬁber/Schaﬀer collateral stimulation. Pairing-induced
potentiation was prevented when the cells were loaded with4 Neural Plasticity
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Figure 2: Pairing GABA-mediated GDPs with Schaﬀer collateral stimulation persistently enhances synaptic strength at glutamatergic CA3-
CA1 connections. (a) Experimental paradigm. (b) The rising phase of GDPs (between the dashed lines) was used to trigger synaptic
stimulation (stim) (c) EPSCs evoked in CA1 principal cells by minimal stimulation of Schaﬀer collateral, before and after pairing (average of
19 responses). (d) Each bar represents the mean peak amplitude of synaptic responses including failures (n = 8) and the paired pulse ratio
(PPR; n = 8), obtained before (open) and after (closed) pairing. (Modiﬁed from [50]).
the calcium chelator BAPTA or when nifedipine (but not
the NMDA receptor antagonist D-(-)-2-amino-5-phospho-
nopentanoic acid) was added to the extracellular medium,
suggesting that activity-dependent changes in synaptic eﬃ-
cacy depend on calcium rise through voltage-dependent
calcium channels and not via NMDA receptors.
Immatureneuronsarecharacterizedbyanelevatednum-
ber of “silent” synapses [40]. These are synapses that do not
conduct at rest either, because the neurotransmitter is not
released when the presynaptic terminal is invaded by an
action potential (presynaptically silent), or because they are
unable to detect the release of the neurotransmitter due
to the lack of the respective receptors on the subsynaptic
membrane (postsynaptically silent). Silent synapses can be
converted into active ones by activity-dependent processes
and this represents the most common mechanism for LTP
induction, not only during development but also in the
mature brain [51]. Interestingly, the pairing procedure was
able to convert silent synapses into active ones. In particular,
in double pulse experiments, pairing caused the appearance
of responses to the ﬁrst stimulus and increased the number
of successes to the second one, indicating that an increased
probability of transmitter release accounts for long-term
increase in synaptic strength. Therefore, calcium entry
through voltage-dependent calcium channels, activated by
thedepolarizingactionofGABAduringGDPs,isinstrumen-
tal in enhancing the number of functional GABAergic and
glutamatergic synapses and/or the probability of GABA and
glutamate release in a Hebbian way. This may contribute to
reﬁne neuronal connectivity before the establishment of the
adult neuronal circuit.
3.MolecularDeterminantsof
GABAergic Synapses Formation
In the adult brain, information processing relies on the inte-
gration of excitatory and inhibitory circuits which use glu-
tamate and GABA/glycine as neurotransmitters, respectively.
The so-called excitatory/inhibitory (E/I) balance represents
a critical condition for the correct functioning of neuronal
networks and it is essential for nearly all brain func-
tions, including representation of sensory information and
cognitive processes. The E/I balance is maintained via
highly regulated homeostatic mechanisms [52]. Neurons
are able to compensate for experimental perturbations by
modulating ion channels, receptors, signaling pathways, and
neurotransmitters. At the molecular level, these processes
require chromatin remodeling, changes in gene expression
and repression, changes in protein synthesis, turnover and
cytoskeleton rearrangement [53]. A disruption of the home-
ostatic control, due to the lack of compensatory changes,
leads to an imbalanced E/I ratio and to the developmental
of neuropsychiatric disorders including mental retardation,
epilepsy and ASDs [21].
During brain maturation, the development of a proper
E/I balance is achieved with the shift of GABA action from
the depolarizing to the hyperpolarizing direction, a process
that in rodents starts appearing toward the end of the ﬁrst,
beginning of the second postnatal week [54]. Disturbances
in the E/I balance may also occur when the formation or
maintenance of one class of synapses prevails over the others.
The selective loss of excitatory or inhibitory synapses can
take place during the initial period of synapse formationNeural Plasticity 5
and consolidation or late in development during activity-
dependent reﬁnement of neuronal circuits and may involve
mutations in genes encoding for ion channels or GABAA
receptor subunits. These would lead to circuits with abnor-
mal activity and prone to seizures [55]. For example, the
disruption in mice of the gabrb3 gene, which encodes for
β3 subunits of GABAA receptors, highly expressed during
development, is suﬃcient to cause phenotypic traits which
parallel those present in the Angelman syndrome [56]. Thus,
mice lacking the β3 subunits exhibit a major reduction
of GABAA receptors, thalamic disinhibition and seizures
associated with learning and memory deﬁcits, poor motor
skills on a repetitive task, hyperactivity, and a disturbed rest-
activity cycle, all features characteristic of children aﬀected
by this neurological disorder. The cellular and molecular
mechanisms underlying these phenomena are still poorly
understood and their comprehension is further complicated
by intrinsic diﬀerences among neuronal types, experimental
conditions and the developmental stage of neurons [57].
During neuronal circuit assembly, GABA signaling pre-
cedes and promotes the formation of glutamatergic synapses
[58]. The sequential development of GABA- and glutamate-
mediated connections is independent on the arrival of aﬀer-
ent inputs but is related to the degree of maturation of tar-
geted cells including changes in dendritic length, in somatic
size and capacitance [58]. While functional GABAergic
synapses require the presence of small apical dendrites in
stratum radiatum of the hippocampus, glutamatergic con-
nectionsrequirethepresenceofdendritesinstratumlacuno-
sum moleculare.
The reﬁnement of GABAergic connections and their
translation into a potent inhibitory network is a protracted
process which extends well beyond the ﬁrst two postnatal
weeks into the adolescent period and is regulated by
neuronal activity and experience. In the visual cortex, for
instance, experience-dependent regulation of the GABAergic
innervation controls the onset of critical periods [59] during
which neuronal circuits display a heightened sensitivity to
environmental stimuli and are greatly shaped by sensory
experience. Thus, a delayed and an acceleratedonset in visual
plasticity can be obtained by negatively or positively interfer-
ing with the GABAergic function, respectively [59]. GABA
signaling itself would be responsible for the development of
inhibitory connections as demonstrated by the observation
that, knocking down GAD67 in basket interneurons severely
impairs GABAergic innervation [20]. These eﬀects may be
attributed to the activity-dependent reduction in GABA
synthesis and signaling following down regulation of GAD67
levels and/or enzyme activity [20].
To be highly eﬃcient, synaptic transmission requires the
presence of clustered postsynaptic receptors localized in pre-
ciseappositiontopresynapticreleasesites.Atinhibitorycon-
nections, this task is accomplished by gephyrin, a tubulin-
binding protein which traps glycine and GABAA receptors in
the right place anchoring them to the cytoskeleton [60].
Interestingly, a recent study has demonstrated that
gephyrin directly interacts with adhesion molecules of the
NLGs family [61] which in turn bind to their presynaptic
partners NRXNs to regulate transmitter release (Figure 3).
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Figure 3: Structural organization of GABAergic synapses. The
postsynapticorganizationcomprisesalargenumberofproteinsthat
allow the correct targeting, clustering and stabilization of GABAA
receptors. Among them gephyrin forms hexagonal lattices that
trap GABAA receptors in precise apposition to presynaptic release
sites. Cell adhesion molecules of the neuroligin-neurexin families
bridge the cleft and ensure transsynaptic signaling, essential for the
maintenance of a proper E/I balance.
Therefore, gephyrin plays a key role not only in stabiliz-
ing GABAA receptors but also in regulating transsynaptic
signaling and in maintaining an appropriate E/I balance.
The NLG-NRXN complexes possess a potent “synaptogenic”
or synapses organizing activities as demonstrated by their
ability to induce presynaptic diﬀerentiation of contact-
ing neuritis when expressed in heterologous nonneuronal
cells. Postsynaptic NLGs promote the assembly of func-
tional presynaptic specializations in axons while presynaptic
NRXNs recruit postsynaptic scaﬀolding proteins and neu-
rotransmitter receptors in dendrites via their interaction
with NLGs [62]. By functionally coupling synaptic calcium
channels with the release machinery, NRXNs are thought to
play an essential role in calcium-triggered neurotransmitters
release [63]. The NLGs family comprises ﬁve diﬀerent
genes (NLG1-NLG5 with various splice variants), which
formhomodimersthroughtheextracellulardomain.Among
these, NLG2 is preferentially associated with GABAergic
synapses, while NLG1 with glutamatergic synapses [64, 65].
The NRXN family includes α-a n dβ-NRXN. Initially, β-
NRXN was considered the main partner for NLG, but
recently, also α-NRXN was found to bind NLG [66].
Unlike β-NRXN that participates in the formation of both
glutamatergic and GABAergic synapses, α-NRXN seems to6 Neural Plasticity
b es p e c i ﬁ cf o rG A B A e r g i cs y n a p s e s[ 67]. Therefore, it is clear
that within a neuronal network, the NLG-NRXN interaction
controlstheformationofbothglutamatergicandGABAergic
synapses [68]. At inhibitory synapses, GABAA receptors
are ﬁrstly assembled in the endoplasmic reticulum from
appropriate subunits and then delivered to the plasma
membrane. Targeting and clustering GABAA receptors at
synaptic and extrasynaptic sites is dynamically regulated by
neuronal activity [69] and requires the precise interplay of
various proteins and active transport processes along the
cytoskeleton [60, 70].
Disrupting endogenous gephyrin with selective antibod-
ies led to a reduction of GABAA receptor clusters [71], an
eﬀect that was associated with a decrease in the density
a n ds i z eo fN L G 2c l u s t e r sa n dw i t hal o s so fG A B A e r g i c
innervation (Kasap, personal communication). Thus, pair
recordings from interconnected cells demonstrated that,
respect to controls, neurons transfected with recombinant
antibodies against gephyrin exhibited a lower probability of
GABA release. This reduction likely involves NLG2 which
is preferentially concentrated at inhibitory synapses and
directly binds gephyrin through a conserved cytoplasmatic
domain [61]. Similarly, at glutamatergic synapses, the NLG-
NRXN complex has been shown to act as a coordinator
between postsynaptic and presynaptic sites [72]. Hence,
overexpressing the glutamatergic scaﬀold protein PSD-95 on
the postsynaptic site enhanced the probability of glutamate
release via a retrograde modulation of neurotransmitter
release which probably involves the NLG-NRXN complex.
From the reported data, it is not surprising that single muta-
tions in genes encoding for adhesion molecules belonging to
the NLG-NRXN families, such as those found in few cases
of ASDs [73], lead to defective architectural structuring of
synapticconnections,molecularassemblyofsynapsesandan
E/I unbalance.
As outlined in the next section, the use of animal models
of ASDs has enabled to investigate the mechanistic basis
of the E/I imbalance for a range of neurodevelopmental
disorders.
4.AlteredGABAergicSignalingin
Animal Models of ASDs
A dysfunction of GABAergic signaling mediates autism-
like stereotypes in the majority of animal models of ASDs
obtained by experimentally manipulating candidate genes
for autism susceptibility or environmental risk factors. The
characteristic ASDs phenotype is often associated with either
a loss or a gain of the GABAergic function. Consistent with
postmortem studies from brain tissues obtained from ASDs
patients [74] alterations in GABA synthesising enzymes
GAD65 and GAD67, in GABA release, in the expression of
particularsubtypesofGABAA receptorshavebeendescribed.
A presynaptic reduction in glutamic acid decarboxylase
1( Gad1) and glutamic acid decarboxylase 2 (Gad2)m R N A
encoding for GAD67 and GAD65, respectively, has been
recently found in mice lacking the Mecp2 gene in GABA
releasing neurons (Viaat-Mecp2−/y,[ 75]). Mutations in the
X-linked Mecp2 gene, which encodes the transcriptional reg-
ulator methyl-CpG-binding protein 2 (MeCP2), cause the
majority of Rett syndrome cases [76–78] which is character-
ized by an apparently normal early development followed by
loss of language skill, motor abnormalities, cognitive deﬁcits,
stereotyped behavior, respiratory dysrhythmias, and seizures
leading sometimes to premature death. Viaat-Mecp2−/y mice
exhibit a signiﬁcant reduction in amplitude (but not in
frequency) of miniature inhibitory postsynaptic currents
(mIPSCs) an eﬀect which occurs in the absence of any
alteration in amplitude or frequency of miniature excitatory
postsynaptic currents (mEPSCs), indicating that MeCP2
deﬁciency in GABAergic neurons has a cell-autonomous
impact on quantal release from glutamatergic neurons [75].
The reduction in GABA content and inhibitory neuro-
transmission aﬀects synaptic plasticity processes as sug-
gested by the impairment of long-term potentiation (LTP)
induced by theta burst stimulation of Schaﬀer collateral
[75]. Previous electrophysiological studies using Mecp2 null
mice, revealed a signiﬁcant reduction in spontaneous ﬁring
associated with a decrease in amplitude of mEPSCs in layer
5 pyramidal neurons as compared to WT control animals
at early presymptomatic and symptomatic stages [79]. In
the hippocampus of Mecp2 null mice, the diminished level
of basal excitatory drive has been shown to contribute,
at the network level, to slow down spontaneous rhythmic
ﬁeld potentials activity, generated by the interplay between
excitation and inhibition [80]. This condition paradoxically
makesthehippocampalnetworkoverresponsivetoexcitatory
stimuli.
Animbalancebetweenexcitationandinhibitionhasbeen
found also in individuals aﬀected by Tuberous sclerosis, a
genetic multisystem disorder characterized by widespread
hamartomas in several organs, including the brain, heart,
skin, eyes, kidney, lung, and liver [81]. Tuberous sclerosis
patients exhibit a variety of neurological disorders including
epilepsy and autism-like disorders. The aﬀected genes are
Tsc1 and Tsc2 encoding hamartin and tuberin, respectively.
The hamartin-tuberin complex inhibits the mammalian-
target-of-rapamycin pathway that controls cell growth and
proliferation [81].
Interestingly, a loss of GABAergic function accounts for
the hyper excitability observed in an animal model of fragile
X syndrome (FXS), a common inherited cause of mental
retardation with language deﬁcits, hyperactivity, autistic
behavior and seizures. FXS is caused by a trinucleotide
expansion of fragile X mental retardation 1 (fmr1)g e n e
which prevents the expression of the encoded protein called
Fragile X mental retardation protein (FMRP, [82]). As the
Mecp2 gene, the fmr1 gene is located in chromosome X
(Xq27.3). The lack of FMRP in animal models of FXS (the
Fmr1-null mouse) leads to an E/I imbalance in favor of
excitation. Among the factors contributing to enhance cell
excitability in Fmr1 KO animals an impairment of GABAer-
gic circuitry [83]a n dad e c r e a s e de x p r e s s i o no fG A B A A
r e c e p t o rs u b u n i t sh a v eb e e nr e p o r t e d[ 84–87]. In subicu-
lar neurons, for example, a down regulation of GABAA-
mediated tonic (but not phasic) inhibition associated with
a reduced expression of α5a n dδ GABAA receptors subunitsNeural Plasticity 7
has been found [88]. These alterations may contribute
to deﬁcits in cognitive functions and to epileptic activity
observed in FXS patients. In contrast, electrophysiological
recordings from spiny neurons in the striatum, involved
in motor control and in speciﬁc aspects of cognition and
motivation, have revealed a selective increase in frequency
of sIPSCs and mIPSCs, probably secondary to an enhanced
probability of transmitter release from GABAergic terminals,
suggesting that modiﬁcations in GABAergic function in
Fmr1 KO mice are region-speciﬁc [89].
Relevant inhibitory synaptic abnormalities (involving
both phasic and tonic GABAA-mediated inhibition), which
may contribute to the abnormal social behavior of Fmr1 null
mice, are present in the basolateral nucleus of the amygdala
[90], which regulates fear and anxiety behaviors.
Linkage and association studies have revealed that the
chromosomal region 15q11-q13 is strongly implicated in
ASDs [91]. Maternal duplications of this region remain one
of the most common cytogenetic abnormalities found in
cases of idiopathic ASDs, which account for 1-2% of cases.
Deletion of this region results in either Angelman or Prader-
Willi syndrome, depending from which parent the deletion
has been inherited [92]. Interestingly, within this chromoso-
malregion,existsageneclusterofGABAA receptors,Gabrb3,
Gabra5,a n dGabrg3, encoding for β3, α5, and γ3s u b -
units, respectively. GABAA receptors are hetero-oligomeric
proteins spanning the membrane to form anion-permeable
channels.Assembledfromeightclassesofsubunitsexhibiting
diﬀerent degrees of homology a large variety of functional
r e c e p t o r sw i t hd i ﬀerent biophysical and pharmacological
properties are expressed in mammalian brain. GABAA
receptors play a crucial role in proliferation, migration, and
diﬀerentiation of precursor cells thus contributing to the
establishment of neuronal circuits [93]. A developmental
deﬁcit of GABAA receptors function would aﬀect neuroge-
nesis and maturation of neuronal network. Among diﬀerent
GABAA receptor genes, the targeted deletion of Gabrb3 gene
encodingfortheβ3subunit,whichishighlyexpressedduring
brain development [94], leads to abnormalities in social
behavior, cognitive deﬁcits, motor stereotypes and seizures,
reminiscent of the ASDs phenotype [56, 92, 95, 96].
Other mutations that aﬀect the GABAergic system con-
cern the homeobox genes Dlx1 and Dlx2, involved in the
development of most telencephalic GABAergic neurons [97].
Interestingly, the human locus with the highest LOD score
for autism susceptibility (D2S2188 on chromosome 2q)
maps very close to the gene encoding for the GABA synthe-
sized enzyme GAD65 and to Dlx1 and Dlx2. Furthermore,
the autism susceptibility locus D7S477 on chromosome 7q
maps within about six megabases of Dlx5 and Dlx6 which
are implicated in the regulation of forebrain GABAergic
neurons [98]. This region hosts the gene encoding for
Reelin, a protein expressed in cortical GABAergic neurons
[99]. Reelin is a signaling protein that plays a pivotal role
in the migration of several neuronal cell types and in the
development of neuronal connections [100, 101]. Reeler
mice, devoid of Reelin, exhibit cytoarchitectonic alterations
in their brain similar to those found in autistic patients [102]
associated with decrease GABA turnover [103].
Interestingly, the removal of the homeobox containing
transcription factors Engrailed-2 (EN2), known to be in-
volved in the regionalization pattering and neuronal diﬀer-
entiation of the midbrain and hindbrain [104]i nm i c e
(En2−/−mice) leads to behavioral abnormalities similar to
those observed in ASDs patients [105]. In addition, these
mice exhibit a reduced expression of parvalbumin and som-
atostatin positive interneurons in the hippocampus, an eﬀect
associated with an increased susceptibility to seizures [105,
Table 1].
While the majority of animal models so far examined
exhibits a loss of GABAergic function, mice carrying the
human R415C mutation in the Nlgn3 gene display a gain
of function. Neuroligins (NLGs) are specialized cell adhesion
molecules that functionally couple the postsynaptic densities
with the transmitter release machinery by forming transsy-
naptic complexes with their presynaptic-binding partners,
neurexins [73]. NLG3 R451C KI mice bear a striking
phenotype with mimics in many aspects that found in ASDs
patients ([106]b u ts e e[ 107]). Functional characterization
of these mice has revealed (in contrast with NLG3 KO
mice) a loss of NLG3 in the forebrain associated with
impaired social interactions and a 50% increase in the
frequency of spontaneous inhibitory events with apparent
no eﬀects on excitatory synaptic transmission [106]. Inter-
estingly, in NLG3 R451C KI mice, the gain of function
is accompanied with a signiﬁcant increase in the level of
the vesicular transporter for GABA, VGAT, and gephyrin, a
postsynaptic scaﬀolding protein, crucial for recruiting and
maintaining neurotransmitter receptors in the right place
andforensuringacorrectE/Ibalance.Whethertheincreased
release of GABA selectively aﬀects only a subset of GABAer-
gic interneurons is still unclear. In addition, this animal
model exhibits an asymmetric reduction of parvalbumin-
positive basket cells across the two hemispheres [108]. How-
ever, immunocytochemical data from postmortem material
obtained from ASDs patients have revealed an increased
density of calbindin-, calretinin-, and parvalbumin-positive
interneurons in the hippocampus [23], a condition that
would alter neuronal signaling and synchronization leading
to cognitive dysfunctions [109]. The enhanced GABAergic
innervation may cause a compensatory downregulation of
GABAA receptors. The reduction in benzodiazepine-binding
sites on GABAA receptors observed in the hippocampus of
autistic patients supports this hypothesis [110].
Among autism risk factors, prenatal or neonatal envi-
ronmental challenges, including early exposure to valproic
acid (VPA), a histone deacetylases inhibitor, are widely used
as animal models of ASDs [111]. The VPA model has been
developed on the basis of the observation that treatment of
epilepsyorbipolardisordersinpregnantwomen(20–24days
after conception) with VPA leads to an increased incidence
of ASDs in their children [112]. A unifying hypothesis
where the core pathology of the autistic brain consists in
hyper-functionality and excessive neuronal processing in
local neuronal microcircuits in prefrontal, somatosensory
cortex, and amygdala, leading to social and environmental
withdrawal has been proposed [113, 114]. Interestingly, as
the neuroligin-3 model, the VPA model of ASDs exhibits an8 Neural Plasticity
Table 1: Main alterations of GABAergic signaling present in diﬀerent animal models of ASDs. For the Rett syndrome, diﬀerent genotypes
are expressed in brackets.
Mouse model Alterations in GABAergic signaling Ref.
R e d u c e dl e v e l so fG A D 6 5a n dG A D 6 7( Viaat-Mecp2−/y) [75]
Reducedinhibitoryquantalsizeinlayer2/3pyramidalneuronsofthesomatosensory
cortex
Mecp 2-KO
(Rett syndrome)
The E/I balance is shifted to favor inhibition over excitation in cortical networks
(Mecp22lox/x,N e s t i n - C r e )
[79]
Reduced frequency of IPSC-based spontaneous rhythmic ﬁeld potentials in the
hippocampus (Mecp2tm1.1Bird)
[80]
Fmr 1-KO
(X fragile)
Down regulation of GABAA-mediated tonic inhibition in the subiculum [88]
Reduced expression of α5a n dδ GABAA receptor subunits in the subiculum
Increased frequency of sIPSCs and mIPSCs in the striatum [89]
Reduction in amplitude and frequency of sIPSCs and mIPSCs [90]
Reduced GABAA-mediated tonic inhibition
[84–87] Reduced GABAergic innervation in the amygdala
Reduced expression of GABAA receptor subunits
Gabrb 3 KO The E/I balance is shifted to favor excitation over inhibition in cortical networks
(EEG recordings)
[56]
Dlx1/Dlx2 KO Abnormal cell migration
Reduction in the number of GABAergic interneurons in the cortex, olfactory bulb
and hippocampus
[97]
Reln-KO Reduced level of GAD67 [103]
Decreased GABA turnover
Reduced expression of parvalbumin- and somatostatin-
En2-KO positive GABAergic interneurons in the hippocampus [115]
Increased susceptibility to seizures
Increased frequency of mIPSC
Nlg3 R451C KI Increased level of VGAT and gephyrin [106]
Asymmetric reduction of PV positive basket cells across cortical hemispheres [108]
valproic acid
The E/I balance is shifted to favor excitation over inhibition in the lateral amygdala
(multi electrode arrays)
[114]
Asymmetric reduction of PV positive basket cells across cortical hemispheres [108]
asymmetric reduction of parvalbumin-positive cells across
the two hemispheres [108]. The disruption of inhibitory
circuits may delay critical periods in speciﬁc ASDs brain
regions [59], thus perturbing γ-oscillations implicated in
high cognitive functions.
5.FuturePerspectives
Although much more work is required to understand the
cellular and molecular mechanisms regulating the E/I bal-
ance at synapses, it is clear from the reviewed data that
GABAergic signaling plays a key role in the construction
of neuronal networks and that disruption of GABAergic
circuits accounts for several neurodevelopmental disorders
including ASDs. A signiﬁcant progress has been made in
characterizing genes involved in synapses formation and
maintenance but their role in the organization of neuronal
circuits is still limited. From a clinical perspective, a
challenged task will be to identify, in animal models of
ASDs, the cellular substrates of microcircuits implicated in
diﬀerent cognitive and behavioral deﬁcits associated with
ASDs. This can be accomplished by using new optogenetic
toolsthatwouldallowtoselectivelyactivateorsilencespeciﬁc
interneuronal populations and to study their functional
consequences [116]. With this technique, GFP fusions of
channelrhodopsin-related proteins and halorhodopsin, can
be delivered into the brain via viral infection. In response
to diﬀerent wavelengths of light, label cells and axons can
be either depolarized (in the case of channelrhodopsin,
[117]) or hyperpolarized (in the case of halorhodopsin),
thus allowing to switch on and oﬀ selective groups of
genetically targeted interneurons and to study the neural
basis of diﬀerent behaviors [118]. This will allow better
understanding the mechanistic bases of ASDs and to develop
new selectively targeted therapeutic tools for most eﬀective
interventions.Neural Plasticity 9
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